Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TELA

+ Watchlist+ Portfolio

TELA Bio, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.76
52-Week Range
$0.50 – $1.50
Market Cap
$35.25M
P/E (TTM)
—
EPS (TTM)
-0.74
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-35.59%
Gross Margin
67.67%
Operating Margin
-40.46%
Profit Margin
-53.57%
Current Ratio
0.61
Debt/Equity
—
Total Debt
$58.04M
Free Cash Flow
$-17.08M
Revenue Growth
-8.40%
Earnings Growth
—
Enterprise Value
$70.63M

Market Snapshot

About

TELA Bio, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials for soft tissue reconstruction. The company manufactures OviTex, a portfolio of advanced reinforced tissue matrices that improve clinical outcomes in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. TELA uses ovine rumen as a biomaterial scaffold.